THE INTELLISTM PLATFORM RECHARGEABLE  SPINAL CORD STIMULATOR

IntellisTM is the world's smallest implantable neurostimulator, offering 95% capacity at 9 years1, personalised programming, and unmatched MRI access*

Download the brochure
The Intellis product family for spinal cord stimulation

Overview

THE INTELLISTM
PLATFORM

SPINAL CORD STIMULATION

The Intellis™ implantable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with current SCS systems and is optimised for the increased energy demands of High Dose (HD) therapy. The lntellis™ Platform uses a tablet with wireless programming and a neurostimulator that can record patient activity around the clock. Snapshot™ reporting allows physicians to monitor a patient’s progress objectively. Additional Medtronic exclusive features – AdaptiveStim™ and SureScan™ full-body MRI technologies – are also part of the Intellis™ Platform.

The EvolveSM Workflow gives standardised guidance on how to use HD and Low Dose (LD) for patients with chronic back and leg pain. The FocusSM Workflow gives guidance on how to apply Peripheral Nerve Stimulation (PNS) for patients with chronic back pain.

OBJECTIVE OUTCOMES

Why are they important?

“Subjective outcomes, such as VAS and ODI are helpful - but not enough. We need more objective data to help us see what is truly happening and changing in the life of a patient who is receiving Spinal Cord Stimulation. It can then help us see them getting better, and help us show them that they are getting better”.

Prof. Maarten Moens, Belgium

SNAPSHOTTM
ON INTELLIS

OBJECTIVE OUTCOMES

MEDTRONIC EXCLUSIVES

  • World’s smallest implantable SCS neurostimulator.
  • Overdrive battery technology optimised for the increased energy demands of HD therapies. 1-hour recharge from empty to full.
  • The EvolveSM Workflow - standardised guidance to simplify the trial and implant experience and optimise patient therapy.
  • AdaptiveStim™ technology adjusts stimulation dose automatically. It delivers the right dose to the right location, as the pain target shifts with different body positions.
  • Supporting patient conversations with access to objective data with Snapshot™ reports.
  • SureScanSM MRI technology gives SCS patients the broadest access to MRI* because it allows MRI scans anywhere on the body, under certain conditions.

ECONOMIC VALUE

pdf 3 instead of 2 patients may be treated with SCS at no extra cost † (.pdf)

Learn more about the cost impact of IPG choice for long-term pain management with SCS.

Read about Intellis Economic Value
Intellis brochure outlining economic benefits

PRODUCT DETAILS

IMPLANTABLE
NEUROSTIMULATOR

  • Smallest fully implantable
    spinal cord neurostimulator
  • 1-hour recharge - empty to full
    (approximate time)
  • Improved battery performance
    with minimal capacity fade
    (<5%)
  • Designed for patient comfort
    and more flexible placement
    during the implant
intellis
#

WIRELESS EXTERNAL NEUROSTIMULATOR

  • Wireless, sterile single-use external neurostimulator simplifies testing during trial and implant
  • Designed for patient comfort and convenience
#
#

CLINICIAN PROGRAMMER

  • Tablet with a touchscreen interface
  • Secure, wireless programming outside the sterile field
  • Tailored programming workflows
  • Electronic transfer of a variety of reports
  • Bluetooth™ Communication
  • Requires the use of the lntellis™ clinician programmer app and communicator device
#

COMBINED PATIENT
PROGRAMMER AND RECHARGER

  • Recharge from a fully depleted battery
  • Easy-to-adjust therapy
  • Easy-to-read interface
  • Large, pliable recharge antenna designed for patient comfort
intellis

COMPATIBLE PRODUCTS 

  • 1x8 Vectris and Vectris SureScan™ MRI percutaneous leads and lnjex anchoring system models 97791 and 97792
  • 16-electrode Specify SureScan™ MRI surgical leads

INDICATIONS

  • The lntellis™ SCS neurostimulation system is indicated for SCS as an aid in the management of chronic, intractable pain of the trunk and/or limbs, peripheral vascular disease, or intractable angina pectoris. 
  • The lntellis™ PNS neurostimulation system is indicated for PNS as an aid in the management of chronic, intractable pain of the posterior trunk.

REQUEST MORE

INFORMATION

CONTACT US
*

MR Safety Triangle Under specific conditions. Requires SureScan™ MRI implantable neurostimulator and leads. Refer to product labelling for full list of conditions.

†

Economic modelling (from a Danish national healthcare perspective) based on costs avoided from less frequent device replacements and associated reduction in procedure-related adverse events with 1 Intellis (RC) implant and 1 replacement surgery2; costs (reported in Danish Kroner and converted to 2020 Euros) are mean cost/patient1; considers battery longevity of 9 years for an Intellis™ SCS device3, and Medtronic’s real-world SCS data for PC battery longevity4 and frequency of procedure-related adverse event management5.

1

R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT Report

2

Holm A et al. Spinal cord stimulation for chronic back and leg pain in Denmark: A cost comparison of rechargeable and non-rechargeable devices. Value in Health. 2020;23: SUPPLEMENT 2, S577.

3

Data on File R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT report 11-JUL-2016.

4

Tinsley J et al. Regional Anesthesia and Pain Medicine, 2019;44: A174.

5

Brinzeu A et al. 2019 Eur. J. Pain 23 1031–44.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.

For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.